Transparency in Negotiation of European Union With Big Pharma on COVID-19 Vaccines

Front Public Health. 2021 Feb 18:9:647955. doi: 10.3389/fpubh.2021.647955. eCollection 2021.

Authors

Salvatore Sciacchitano^{1

2}, Armando Bartolazzi^{3

4}

Affiliations

¹ Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
² Laboratory of Biomedical Research, Niccolò Cusano University Foundation, Rome, Italy.
³ Laboratory of Surgical and Experimental Pathology, St Andrea University Hospital, Rome, Italy.
⁴ Department of Oncology-Pathology, Cancer Center Karolinska Universitetssjukhuset Solna, Stockholm, Sweden.

No abstract available

Keywords: COVID-19; advance purchase agreements; big pharmaceutical companies; transparency in negotiation; vaccines.

MeSH terms

COVID-19 Vaccines / economics*
Drug Costs
Drug Industry*
European Union
Negotiating*

Substances

COVID-19 Vaccines